Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2) [Phase 4]

View source ↗

Summary

Phase 4 SURPASS-SWITCH-2 study of tirzepatide in adults with type 2 diabetes switching from a GLP-1 receptor agonist has completed and posted results in 2024. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2024-12-13